ArticleBlood2015

Mutational spectrum of myeloid malignancies with inv(3)/t(3;3) reveals a predominant involvement of RAS/RTK signaling pathways.

Stefan Gröschel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.